Muran Ding

BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic solid tumor: Results from a first-in-human phase 1 study.

Li Zhang, Yuxiang Ma, Yuanyuan Zhao et al. · Journal of Clinical Oncology · 2023 · 25 citations

Immunology, Pathology, Pharmacotherapy +18

ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern

Tsung-I Tsai, Jahan S. Khalili, Mark Gilchrist et al. · Antiviral Research · 2022 · 21 citations · Full text

Viral Pathogenesis, Immunology, Pathology +19

SI-B001 plus chemotherapy in patients with locally advanced or metastatic EGFR/ALK wild-type non-small cell lung cancer: A phase II, multicenter, open-label study.

Yuanyuan Zhao, Li Zhang, Wenfeng Fang et al. · Journal of Clinical Oncology · 2023 · 17 citations

Phase Ii, Medicine, Immunology +15

Short-sale refinancing and price adjustment speed to bad news: Evidence from a quasi-natural experiment in China

Kaijuan Gao, Muran Ding · China Journal of Accounting Research · 2019 · 16 citations · Full text

Human eukaryotic elongation factor 1A forms oligomers through specific cysteine residues

Tao Liu, Yang Yu, Di Wang et al. · Acta Biochimica et Biophysica Sinica · 2015 · 10 citations · Full text